4basebio (4BB) Competitors GBX 1,104 -16.00 (-1.43%) As of 02/21/2025 03:08 AM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsHeadlinesInsider Trades 4BB vs. SLN, PRTC, OXB, HZD, VRP, FARN, ARIX, BVXP, AVCT, and CIRShould you be buying 4basebio stock or one of its competitors? The main competitors of 4basebio include Silence Therapeutics (SLN), PureTech Health (PRTC), Oxford Biomedica (OXB), Horizon Discovery Group plc (HZD.L) (HZD), Verona Pharma plc (VRP.L) (VRP), Faron Pharmaceuticals Oy (FARN), Arix Bioscience (ARIX), Bioventix (BVXP), Avacta Group (AVCT), and Circassia Group (CIR). These companies are all part of the "biotechnology" industry. 4basebio vs. Silence Therapeutics PureTech Health Oxford Biomedica Horizon Discovery Group plc (HZD.L) Verona Pharma plc (VRP.L) Faron Pharmaceuticals Oy Arix Bioscience Bioventix Avacta Group Circassia Group Silence Therapeutics (LON:SLN) and 4basebio (LON:4BB) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their earnings, community ranking, profitability, risk, institutional ownership, valuation, dividends, analyst recommendations and media sentiment. Do institutionals & insiders hold more shares of SLN or 4BB? 2.0% of 4basebio shares are owned by institutional investors. 68.4% of 4basebio shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term. Does the MarketBeat Community believe in SLN or 4BB? Silence Therapeutics received 203 more outperform votes than 4basebio when rated by MarketBeat users. CompanyUnderperformOutperformSilence TherapeuticsOutperform Votes20368.81% Underperform Votes9231.19% 4basebioN/AN/A Which has better earnings and valuation, SLN or 4BB? Silence Therapeutics has higher revenue and earnings than 4basebio. 4basebio is trading at a lower price-to-earnings ratio than Silence Therapeutics, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioSilence Therapeutics£11.35M0.00N/A-£48.60N/A4basebio£311K454.73-£9.84M-£0.78-1,415.38 Is SLN or 4BB more profitable? Silence Therapeutics' return on equity of 0.00% beat 4basebio's return on equity.Company Net Margins Return on Equity Return on Assets Silence TherapeuticsN/A N/A N/A 4basebio N/A -231.29%-54.30% Does the media favor SLN or 4BB? In the previous week, 4basebio had 2 more articles in the media than Silence Therapeutics. MarketBeat recorded 2 mentions for 4basebio and 0 mentions for Silence Therapeutics. 4basebio's average media sentiment score of 0.37 beat Silence Therapeutics' score of 0.00 indicating that 4basebio is being referred to more favorably in the news media. Company Overall Sentiment Silence Therapeutics Neutral 4basebio Neutral SummarySilence Therapeutics and 4basebio tied by winning 5 of the 10 factors compared between the two stocks. Get 4basebio News Delivered to You Automatically Sign up to receive the latest news and ratings for 4BB and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart 4BB vs. The Competition Export to ExcelMetric4basebioBiotechnology IndustryMedical SectorLON ExchangeMarket Cap£141.42M£118.03M£5.84B£2.64BDividend YieldN/A3.69%4.75%4.98%P/E Ratio-1,415.383.2026.74162.45Price / Sales454.734,826.69435.46314,061.87Price / Cash16.0813.0138.0128.13Price / Book-26.9347.077.645.16Net Income-£9.84M-£87.82M£3.19B£5.76B7 Day Performance-1.43%0.33%-2.12%-1.01%1 Month Performance-7.09%3.62%-0.45%-0.85%1 Year Performance47.20%98.73%16.26%39.61% 4basebio Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)4BB4basebioN/AGBX 1,104-1.4%N/A+52.3%£141.42M£311,000.00-1,415.38101SLNSilence TherapeuticsN/AN/AN/AN/A£480.35M£11.35M-11.01100High Trading VolumePRTCPureTech Health2.0093 of 5 starsGBX 146.40+0.3%GBX 455+210.8%-24.1%£439.76M£521,320.79-6.01300News CoverageGap UpOXBOxford Biomedica2.519 of 5 starsGBX 387-0.5%GBX 433.33+12.0%+102.0%£411.39M£98.31M-2.88891News CoverageHZDHorizon Discovery Group plc (HZD.L)N/AN/AN/AN/A£302.98M£54.63M-33.55416VRPVerona Pharma plc (VRP.L)N/AN/AN/AN/A£228MN/A-1.6822Gap UpFARNFaron Pharmaceuticals OyN/AGBX 168.50+0.6%N/A+32.3%£226.21MN/A-4.5134ARIXArix BioscienceN/AN/AN/AN/A£183.73M£14.16M1,290.919BVXPBioventixN/AGBX 2,900-0.9%N/A-41.7%£151.85M£13.65M18.7612Negative NewsAVCTAvacta GroupN/AGBX 39.37-5.4%N/A-53.9%£149.55M£26.29M-5.07120High Trading VolumeCIRCircassia GroupN/AN/AN/AN/A£142.66M£27.90M3,400.00111Gap Down Related Companies and Tools Related Companies Silence Therapeutics Competitors PureTech Health Competitors Oxford Biomedica Competitors Horizon Discovery Group plc (HZD.L) Competitors Verona Pharma plc (VRP.L) Competitors Faron Pharmaceuticals Oy Competitors Arix Bioscience Competitors Bioventix Competitors Avacta Group Competitors Circassia Group Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (LON:4BB) was last updated on 2/22/2025 by MarketBeat.com Staff From Our PartnersThe Real Hillbilly ElegyThe mountains of Appalachia are incredible to behold. Spanning thousands of miles across Alabama, Kentucky...Porter & Company | Sponsored$5,000 DOGE check?Elon Musk's DOGE agenda just took a very surprising turn... Earlier this week, reports emerged that a porti...Altimetry | SponsoredElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredEx-CIA Advisor: Trump 2.0 Could “Send Gold to $10,000”Experts forecast gold's price racing to $4,000… and an ex-CIA advisor predicts we'll see gold hit $10,000. ...Colonial Metals | SponsoredThis Crypto Is Set to Explode in FebruaryIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredBuy NVDA Now? After weeks of volatility, did President Trump just turn Nvidia (NVDA) into a raging BUY? The beloved chip...Chaikin Analytics | Sponsored2025 AI Blueprint features Nvidia’s march to $5 trillionNvidia is now one of the most valuable companies in the world. It currently ranks second, just behind Apple...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding 4basebio PLC Please log in to your account or sign up in order to add this asset to your watchlist. Share 4basebio With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free 4BB Stock Alerts